| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 10/01/1997 | EP0797455A1 Recombinant vectors for permanent reconstitution of liver and treatment of hepatitis c |
| 10/01/1997 | EP0797445A2 Use of bioassimilable boron compounds for the control of subviral pathogenic agents |
| 10/01/1997 | CN1161058A Intracellular isoform of the interleukin-1 receptor antagonist |
| 10/01/1997 | CN1161040A Bicyclic tetrahydro pyrazolopyridines and their use as medicaments |
| 10/01/1997 | CN1036006C Antibiotic compound carbapenem |
| 10/01/1997 | CN1036005C Preparation of parmaceutical composition containing derivative of 7-pyrrolidinyl-3-chinolon and-naphthyridon carboxylic acid |
| 10/01/1997 | CN1035986C Process for preparing composition of sustained release bolus |
| 09/30/1997 | US5672711 Condensation, acylation; forming cefotaxime |
| 09/30/1997 | US5672700 Antibiotics |
| 09/30/1997 | US5672698 Preparation of 2',3'-didehydro-3'-deoxythymidine from 5-methyluridine |
| 09/30/1997 | US5672697 Form oligonucleotides stable to nuclease degradation |
| 09/30/1997 | US5672695 Modified ribozymes |
| 09/30/1997 | US5672625 Sulfonic stilbene derivatives in the treatment of viral diseases |
| 09/30/1997 | US5672607 Antiviral naphthoquinone compounds, compositions and uses thereof |
| 09/30/1997 | US5672600 Antimicrobial dithiocarbamoyl quinolones |
| 09/30/1997 | US5672598 Matrix metalloprotease inhibitors |
| 09/30/1997 | US5672594 Anticarcinogenic,-tumor and -parasitic agents; viricides; fungicides; bactericides; hiv virus |
| 09/30/1997 | US5672586 Herpes ribonucleotide reductase inhibitors |
| 09/30/1997 | US5672584 Modified with end groups |
| 09/30/1997 | US5672356 Bioadhesive pharmaceutical composition for the controlled release of active principles |
| 09/30/1997 | CA2055463C Antiviral therapy using thiazine and xanthene dyes |
| 09/25/1997 | WO1997035014A1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF IλB$g(a) |
| 09/25/1997 | WO1997035010A1 Chemokine alpha 2 |
| 09/25/1997 | WO1997034897A1 Fused imidazole derivatives as multidrug resistance modulators |
| 09/25/1997 | WO1997034894A1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 09/25/1997 | WO1997034644A1 Topical formulations for the treatment of nail psoriasis |
| 09/25/1997 | WO1997034629A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | WO1997034623A1 Solid phase lipoglycopeptide library, compositions and methods |
| 09/25/1997 | WO1997034621A1 Hla-a2.1 binding peptides and their uses |
| 09/25/1997 | WO1997034599A2 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 09/25/1997 | WO1997034566A2 Electrophilic ketones for the treatment of herpesvirus infections |
| 09/25/1997 | WO1997034489A1 Antibacterially active marine algae extracts from the class diatomatae and methods of use |
| 09/25/1997 | WO1997034472A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | WO1997030082A3 Antifungic and antibacterial peptide |
| 09/25/1997 | WO1997026867A3 Solid instant-release forms of administration and process for producing the same |
| 09/25/1997 | WO1997019113A3 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 09/25/1997 | WO1997012043A3 Hcv ns3 protein fragments having helicase activity and improved solubility |
| 09/25/1997 | CA2250320A1 Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
| 09/25/1997 | CA2250068A1 Electrophilic ketones for the treatment of herpesvirus infections |
| 09/25/1997 | CA2249997A1 Chemokine alpha 2 |
| 09/25/1997 | CA2249994A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | CA2249571A1 Antibacterially active marine algae extracts from the class diatomatae and methods of use |
| 09/25/1997 | CA2249551A1 A kinase capable of site-specific phosphorylation of i.kappa.b.alpha. |
| 09/25/1997 | CA2249412A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | CA2249323A1 Solid phase lipoglycopeptide library, compositions and methods |
| 09/25/1997 | CA2248977A1 Topical formulations for the treatment of nail psoriasis |
| 09/24/1997 | EP0796861A1 Silated derivatives of salicilic acid with desquamative properties |
| 09/24/1997 | EP0796858A1 Triazole antifungal agents |
| 09/24/1997 | EP0796841A1 Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity |
| 09/24/1997 | EP0796620A1 An anti-viral and anti-cancer agent from "Aspalathus Linearis" |
| 09/24/1997 | EP0796341A2 Identification of genes |
| 09/24/1997 | EP0796332A1 Neisseria meningitidis subunit tbp2 |
| 09/24/1997 | EP0796331A2 Production and administration of high titer recombinant retroviruses |
| 09/24/1997 | EP0796326A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 09/24/1997 | EP0796276A1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 09/24/1997 | EP0796273A1 Variants of human papilloma virus antigens |
| 09/24/1997 | EP0796263A1 Cephem compounds and pharmaceutical use thereof |
| 09/24/1997 | EP0796262A1 7-alkylidene cephalosporanic acid derivatives and methods of using the same |
| 09/24/1997 | EP0796260A1 Rapamycin 42-oximes and hydroxylamines |
| 09/24/1997 | EP0796249A1 Compounds for inhibition of gastric acid secretion |
| 09/24/1997 | EP0796101A1 Compositions and methods for inhibiting fungal cell wall formation |
| 09/24/1997 | EP0796094A1 Vitamin e and derivatives prevent damage in red cells sterilized by phthalocyanines and light |
| 09/24/1997 | EP0653207B1 Aids virus infection inhibitor composition |
| 09/24/1997 | CN1160402A Purine and guanine compounds as inhibitors of PNP |
| 09/24/1997 | CN1160356A Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 09/24/1997 | CN1160350A HIV protease inhibitor combination |
| 09/24/1997 | CN1160052A New crystal modification of quinolinecarboxylic acid hydrochloride, process for its preparation and pharmaceutical formulations comprising this modification |
| 09/24/1997 | CN1160051A New substituted oxazolidinones |
| 09/24/1997 | CN1159950A Bioadhesive pharmaceutical composition for controlled release of active principles |
| 09/24/1997 | CN1035946C Process for preparing heterocyclic compounds |
| 09/24/1997 | CN1035945C Process for preparing 5-alkylquinolonecarboxylic acid derivs. |
| 09/24/1997 | CN1035925C Method for preparation of cytotropic non-homogeneous molecular lipid |
| 09/23/1997 | US5670675 Retroviral protease inhibiting compounds |
| 09/23/1997 | US5670638 2-bromo- and 2-nitroxy derivatives of 3-bromo- and 3,3-dibromo-4-oxo-azetidines, and preparation |
| 09/23/1997 | US5670633 Sugar modified oligonucleotides that detect and modulate gene expression |
| 09/23/1997 | US5670630 Expression of hepatitis B S and preS2 proteins in methylotrophic |
| 09/23/1997 | US5670527 Cytokine inhibitors useful in treating asthma, osteoporosis, arthritis, inflammation, sepsis, cardiovascular disorders, diabetes, multiple sclerosis, skin disorders |
| 09/23/1997 | US5670520 Method for inhibiting virus replication in mammalian cells using carbostyil derivatives |
| 09/23/1997 | US5670518 Antitumor agents; viricides |
| 09/23/1997 | US5670504 2,6-diaryl pyridazinones with immunosuppressant activity |
| 09/23/1997 | US5670497 Cyclic hydrazine compounds |
| 09/23/1997 | US5670489 Oligonucleotide analogues |
| 09/23/1997 | US5670367 Recombinant fowlpox virus |
| 09/23/1997 | US5670361 HIV-specific ribozymes |
| 09/23/1997 | US5670153 Immunoreactive polypeptide compositions |
| 09/23/1997 | US5670152 Containing hepatitis virus epitopes |
| 09/23/1997 | US5670143 Anti-HIV pharmaceutical formulations |
| 09/23/1997 | CA2069024C Processes for the diastereoselective synthesis of nucleosides |
| 09/18/1997 | WO1997034137A2 Methods of the identification of pharmaceutically active compounds |
| 09/18/1997 | WO1997034008A1 Vectors based on recombinant defective viral genomes, and their use in the formulation of vaccines |
| 09/18/1997 | WO1997034001A1 Clostridium perfringens vaccines |
| 09/18/1997 | WO1997033996A2 Human bikunin |
| 09/18/1997 | WO1997033991A1 Short external guide sequences |
| 09/18/1997 | WO1997033911A1 Persephin and related growth factors |
| 09/18/1997 | WO1997033904A1 Death domain containing receptors |
| 09/18/1997 | WO1997033896A1 Polyvalent polymers for the treatment of rotavirus infection |
| 09/18/1997 | WO1997033615A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 09/18/1997 | WO1997033604A1 Treatment of hiv-infection by interfering with host cell cyclophilin receptor activity |
| 09/18/1997 | WO1997033602A1 Peptides with increased binding affinity for hla molecules |
| 09/18/1997 | WO1997022354A3 Use of a medicament and use of mixture of substances to produce a medicament |